Pirfenidone and Vitamin D Ameliorate Cardiac Fibrosis Induced by Doxorubicin in Ehrlich Ascites Carcinoma Bearing Mice: Modulation of Monocyte Chemoattractant Protein-1 and Jun N-terminal Kinase-1 Pathways

Pharmaceuticals - Tập 13 Số 11 - Trang 348
Mohamed A. Saleh1,2, Samar A. Antar3, Reem M. Hazem4, Mona F. El-Azab4
1Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, UAE
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 33516, Egypt
3Department of Pharmacology & Toxicology, Faculty of Pharmacy, Horus University, New Damietta 34518, Egypt
4Department of Pharmacology & Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt

Tóm tắt

Treatment of breast cancer with doxorubicin causes numerous side effects, of which cardiac fibrosis is considered the main one. This study was designed to investigate the underlying molecular mechanisms for the potential anti-fibrotic effect of pirfenidone and vitamin D against doxorubicin-induced cardiac fibrosis. Seventy mice carrying solid Ehrlich’s ascites carcinoma (EAC) discs on the ventral side were treated with orally administered pirfenidone (500 mg/kg) and intraperitoneal injection of vitamin D (0.5 µg/kg) either individually or in combination with a doxorubicin (15 mg/kg; i.p.) single dose. All treatments commenced one week post-tumor inoculation and continued for 14 days. Compared to control EAC mice, the doxorubicin group showed a significant increase in heart and left ventricle weights, troponin T, and creatinine kinase serum levels. Furthermore, the doxorubicin group depicts a high expression of monocyte chemoattractant protein (MCP-1), nuclear factor-kappa B (NF-κB), transforming growth factor-beta 1 (TGF-β1), smad3, Jun N-terminal Kinase-1 (JNK1), and alpha-smooth muscle actin (α-SMA). Treatment with pirfenidone or vitamin D significantly decreased all of these parameters. Furthermore, the expression of smad7 was downregulated by doxorubicin and improved by pirfenidone or vitamin D. Furthermore, all treated groups showed a marked decrease in tumor weight and volume. Current data demonstrate that pirfenidone and vitamin D represent an attractive approach to ameliorate the cardiac fibrosis produced by doxorubicin through inhibiting both JNK1 signaling and MCP-1 inflammatory pathways, thus preserving heart function. Further, this combination demonstrated an anti-tumor effect to combat breast cancer.

Từ khóa


Tài liệu tham khảo

Mustafa, 2016, Breast cancer: Detection markers, prognosis, and prevention, IOSR Dent. Med. Sci., 15, 73, 10.9790/0853-1508117380

Wynn, 2008, Cellular and molecular mechanisms of fibrosis, J. Pathol., 214, 199, 10.1002/path.2277

Sahyon, 2020, Chemoprotective role of an extract of the heart of the Phoenix dactylifera tree on adriamycin-induced cardiotoxicity and nephrotoxicity by regulating apoptosis, oxidative stress and PD-1 suppression, Food Chem. Toxicol., 135, 111045, 10.1016/j.fct.2019.111045

Dana, 1993, Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy, J. Clin. Oncol., 11, 644, 10.1200/JCO.1993.11.4.644

Karabekmez, 2018, Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells, Sci. Rep., 8, 13672, 10.1038/s41598-018-31939-9

Mohebbati, 2016, Adriamycin-induced oxidative stress is prevented by mixed hydro-alcoholic extract of Nigella sativa and Curcuma longa in rat kidney, Avicenna J. Phytomed., 6, 86

Yamashita, 2017, Podocyte-specific NF-kappaB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice, Clin. Exp. Nephrol., 21, 16, 10.1007/s10157-016-1268-6

Wong, 2017, Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions, J. Biol. Chem., 292, 16804, 10.1074/jbc.R117.789271

Wang, 2013, Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation, Cardiology, 126, 1, 10.1159/000351179

Hasdemir, 2017, Effect of Pirfenidone on Vascular Proliferation, Inflammation and Fibrosis in an Abdominal Adhesion Rat Model, J. Investig. Surg., 30, 26, 10.1080/08941939.2016.1215578

Schaefer, 2011, Antifibrotic activities of pirfenidone in animal models, Eur. Respir. Rev., 20, 85, 10.1183/09059180.00001111

Artaza, 2009, Vitamin D and the cardiovascular system, Clin. J. Am. Soc. Nephrol., 4, 1515, 10.2215/CJN.02260409

Kim, 2008, Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004), Am. J. Cardiol., 102, 1540, 10.1016/j.amjcard.2008.06.067

Chen, 2011, Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy, Circulation, 124, 1838, 10.1161/CIRCULATIONAHA.111.032680

Liu, T., Zhang, L., Joo, D., and Sun, S.C. (2017). NF-kappaB signaling in inflammation. Signal Transduct. Target. Ther., 2.

Sun, 2018, miR-24 and miR-122 Negatively Regulate the Transforming Growth Factor-beta/Smad Signaling Pathway in Skeletal Muscle Fibrosis, Mol. Ther. Nucleic Acids, 11, 528, 10.1016/j.omtn.2018.04.005

Holopainen, 2015, Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodeling, Proc. Natl. Acad. Sci. USA, 112, 13063, 10.1073/pnas.1517810112

Lan, 2011, Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation, Int. J. Biol. Sci., 7, 1056, 10.7150/ijbs.7.1056

Gdo, 2002, Alpha-lipoic acid ameliorates myocardial toxicity induced by doxorubicin, Pharmacol. Res., 46, 499, 10.1016/S1043661802002311

Kozono, 2013, Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells, Cancer Res., 73, 2345, 10.1158/0008-5472.CAN-12-3180

Polydorou, 2017, Pirfenidone normalizes the tumor microenvironment to improve chemotherapy, Oncotarget, 8, 24506, 10.18632/oncotarget.15534

Erkan, 2007, Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity, Gastroenterology, 132, 1447, 10.1053/j.gastro.2007.01.031

Morra, 2011, Periostin expression and epithelial-mesenchymal transition in cancer: A review and an update, Virchows Arch., 459, 465, 10.1007/s00428-011-1151-5

Krishnan, 2011, Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D, Annu. Rev. Pharmacol. Toxicol., 51, 311, 10.1146/annurev-pharmtox-010510-100611

Trump, 2010, Vitamin D: Considerations in the continued development as an agent for cancer prevention and therapy, Cancer J., 16, 1, 10.1097/PPO.0b013e3181c51ee6

Krishnan, 2010, Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling, J. Steroid Biochem. Mol. Biol., 121, 343, 10.1016/j.jsbmb.2010.02.009

Dion, 2000, The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells, Cancer Res., 60, 4412

Ahmed, 2014, Prognostic significance of elevated troponin in non-cardiac hospitalized patients: A systematic review and meta-analysis, Ann. Med., 46, 653, 10.3109/07853890.2014.959558

Manne, 2013, Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse, Int. J. Oncol., 42, 2134, 10.3892/ijo.2013.1893

Yu, 2018, Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products, Phytomedicine, 40, 125, 10.1016/j.phymed.2018.01.009

Liu, 2005, Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure, Am. J. Physiol. Heart Circ. Physiol., 289, H660, 10.1152/ajpheart.00268.2005

Lee, 2006, Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure, Circulation, 114, 1703, 10.1161/CIRCULATIONAHA.106.624320

Park, 1999, Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism, Am. J. Kidney Dis., 33, 73, 10.1016/S0272-6386(99)70260-X

Khansari, 2009, Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer, Recent Pat. Inflamm. Allergy Drug Discov., 3, 73, 10.2174/187221309787158371

Chabaud, 2001, Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: Regulation by soluble receptors and Th2 cytokines, J. Immunol., 167, 6015, 10.4049/jimmunol.167.10.6015

Fernandes, 2015, Characterization of the inflammatory response during Ehrlich ascitic tumor development, J. Pharmacol. Toxicol. Methods, 71, 83, 10.1016/j.vascn.2014.09.001

Romano, 2004, Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells, Eur. J. Cancer, 40, 2829, 10.1016/j.ejca.2004.08.017

Hata, 2002, IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts, Am. J. Physiol. Gastrointest. Liver Physiol., 282, G1035, 10.1152/ajpgi.00494.2001

Hohensinner, 2006, Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia, FEBS Lett., 580, 3532, 10.1016/j.febslet.2006.05.043

Nakanishi, 2004, Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1beta at a step of NF-kappaB DNA binding in hepatocytes, J. Hepatol., 41, 730, 10.1016/j.jhep.2004.07.007

Shinoda, 2009, Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis, Respiration, 78, 285, 10.1159/000207617

Inomata, 2014, Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis, Respir. Res., 15, 16, 10.1186/1465-9921-15-16

Blackwell, 1997, The role of nuclear factor-kappa B in cytokine gene regulation, Am. J. Respir. Cell Mol. Biol., 17, 3, 10.1165/ajrcmb.17.1.f132

Cheng, 2016, MiR-143-3p controls TGF-beta1-induced cell proliferation and extracellular matrix production in airway smooth muscle via negative regulation of the nuclear factor of activated T cells 1, Mol. Immunol., 78, 133, 10.1016/j.molimm.2016.09.004

Kuwahara, 2002, Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats, Circulation, 106, 130, 10.1161/01.CIR.0000020689.12472.E0

Elexpuru, 1997, Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGFbeta)-like activity but lack receptors with TGFbeta-binding capacity, Mol. Cell Biochem., 170, 153, 10.1023/A:1006809604193

Polegato, 2015, Acute doxorubicin-induced cardiotoxicity is associated with matrix metalloproteinase-2 alterations in rats, Cell Physiol. Biochem., 35, 1924, 10.1159/000374001

Fan, 2012, Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease, Fibrogenesis Tissue Repair, 5, 15, 10.1186/1755-1536-5-15

Heldin, 2009, Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition, Curr. Opin. Cell Biol., 21, 166, 10.1016/j.ceb.2009.01.021

Chen, 2006, TGF-beta1 and integrin synergistically facilitate the differentiation of rat podocytes by increasing alpha-smooth muscle actin expression, Transl. Res., 148, 134, 10.1016/j.trsl.2006.03.008

Meng, 2012, Disruption of Smad4 impairs TGF-beta/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro, Kidney Int., 81, 266, 10.1038/ki.2011.327

Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-beta family signalling, Nature, 425, 577, 10.1038/nature02006

Grynberg, 2017, The JNK Signaling Pathway in Renal Fibrosis, Front. Physiol., 8, 829, 10.3389/fphys.2017.00829

Chen, 2018, Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-kappaB pathway, Metabolism, 83, 256, 10.1016/j.metabol.2018.03.004

Huang, 2007, Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells, Kidney Int., 72, 45, 10.1038/sj.ki.5002243

Renu, 2018, Molecular mechanism of doxorubicin-induced cardiomyopathy—An update, Eur. J. Pharmacol., 818, 241, 10.1016/j.ejphar.2017.10.043

Stahnke, T., Kowtharapu, B.S., Stachs, O., Schmitz, K.P., Wurm, J., Wree, A., Guthoff, R.F., and Hovakimyan, M. (2017). Suppression of TGF-beta pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro. PLoS ONE, 12.

Isaka, Y. (2018). Targeting TGF-beta Signaling in Kidney Fibrosis. Int. J. Mol. Sci., 19.

Li, 2017, Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis, Nephrology, 22, 589, 10.1111/nep.12831

Ramirez, 2010, Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells, J. Steroid Biochem. Mol. Biol., 118, 142, 10.1016/j.jsbmb.2009.11.004

Shany, 2016, Vitamin D and Myofibroblasts in Fibrosis and Cancer: At Cross-purposes with TGF-beta/SMAD Signaling, Anticancer Res., 36, 6225, 10.21873/anticanres.11216

Bi, 2016, c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation, J. Steroid Biochem. Mol. Biol., 163, 164, 10.1016/j.jsbmb.2016.05.009

Arfian, 2016, Vitamin D Attenuates Kidney Fibrosis via Reducing Fibroblast Expansion, Inflammation, and Epithelial Cell Apoptosis, Kobe J. Med. Sci., 62, E38

Lazarus, 1966, Determination of sensitivity of individual biopsy specimens to potential inhibitory agents: Evaluation of some explant culture methods as assay systems, Cancer Chemother. Rep., 50, 543

Minotti, 2004, Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity, Pharmacol. Rev., 56, 185, 10.1124/pr.56.2.6